Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?

• Principais autores: Elif Hilal Vural (Autor), Tolga Kaskati (Autor), İsmail Mert Vural (Autor), Mustafa Asım Özalp (Autor), Bülent Gümüşel (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objectives: Cancer diagnosis is increasing day by day all over the world. Deaths due to cancer are among the most common causes of death. Access to cancer drugs is a priority of health policies. The aim of this study is to evaluate access to cancer drugs through drug box sales data by modeling popul...